
cTAP Announces Two Research Publications Categorizing and Predicting Disease Progression in Duchenne Muscular Dystrophy
Read More
RARECast: A Controversial Approval for a Duchenne Drug and What Lies Ahead
Read More
Rare Disease Reports: FDA Accepts Sarepta’s Sarepta’s NDA for Eteplirsen. PDUFA Date Set
Read More